Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Pittsburgh Clinical Genomics Laboratory, |
RCV004785150 | SCV005397703 | uncertain significance | Snijders Blok-Campeau syndrome | 2024-06-17 | criteria provided, single submitter | clinical testing | This sequence variant is a single nucleotide substitution (G>A) at position 14 bases prior to CHD3 exon 8. This variant is absent from ClinVar and, to our knowledge, has not been observed in the clinical literature in an individual affected by a CHD3-related disorder. This variant is present in 8 of 398682 alleles (0.0020%) in the gnomAD population dataset. In silico splice predictors indicate that this variant may disrupt the canonical splicing of intron 7. However, this prediction has not been evaluated in a functional study, to our knowledge. At this time, there is insufficient evidence to determine if this variant is pathogenic or benign. Therefore, we consider this a variant of uncertain significance. ACMG Criteria: PM2, PP3 |